Db Fitzpatrick & Co, Inc Edwards Lifesciences Corp Transaction History

Db Fitzpatrick & Co, Inc

$113 Million
Q3 2024

A detailed history of Db Fitzpatrick & Co, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Db Fitzpatrick & Co, Inc holds 21,006 shares of EW stock, worth $1.57 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

21,006

Previous 20,940 0.32%

Holding current value

$1.57 Million

Previous $1.93 Million 28.34%

% of portfolio

1.23%

Previous 1.8%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$59.7 - $93.78 $3,940 - $6,189	66 Added 0.32%	21,006 $1.39 Million
Q2 2024 Jul 17, 2024	SELL	$84.3 - $94.31 $12,982 - $14,523	-154 Reduced 0.73%	20,940 $1.93 Million
Q1 2024 Apr 19, 2024	BUY	$72.54 - $95.56 $4,134 - $5,446	57 Added 0.27%	21,094 $2.02 Million
Q4 2023 Jan 23, 2024	BUY	$61.71 - $77.76 $198,274 - $249,842	3,213 Added 18.03%	21,037 $1.6 Million
Q3 2023 Nov 01, 2023	BUY	$69.28 - $93.38 $4,641 - $6,256	67 Added 0.38%	17,824 $1.23 Million
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $74,164 - $85,934	-911 Reduced 4.88%	17,757 $1.68 Million
Q1 2023 Apr 24, 2023	BUY	$74.26 - $84.51 $78,864 - $89,749	1,062 Added 6.03%	18,668 $1.54 Million
Q4 2022 Jan 24, 2023	BUY	$68.3 - $87.44 $1.2 Million - $1.54 Million	17,606 New	17,606 $0
Q3 2022 Oct 20, 2022	SELL	$82.37 - $107.29 $115,894 - $150,957	-1,407 Reduced 10.18%	12,410 $1.03 Million
Q2 2022 Jul 28, 2022	BUY	$86.5 - $128.27 $45,585 - $67,598	527 Added 3.97%	13,817 $1.31 Million
Q1 2022 Apr 22, 2022	BUY	$101.96 - $128.34 $30,587 - $38,502	300 Added 2.31%	13,290 $1.56 Million
Q4 2021 Feb 03, 2022	BUY	$106.37 - $130.68 $1.38 Million - $1.7 Million	12,990 New	12,990 $1.68 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Db Fitzpatrick & Co, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Db Fitzpatrick & Co, Inc with notifications on news.

Account

Db Fitzpatrick & Co, Inc Edwards Lifesciences Corp Transaction History